Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), bought 154,000 shares at $11.12 ($1.7M) on 2021-08-25, disclosed to the SEC on 2021-08-27.
Open-market purchase of $1.7M EOLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.12 | 44,000 | $489K | 28.7% |
| 2 | $11.12 | 44,000 | $489K | 28.7% |
| 3 | $11.02 | 66,000 | $727K | 42.6% |
| Total | $11.08 avg | 154,000 | $1.7M | 100% |
| Filing → |
| EOLS | BUY | 2023-02-06 | $565K | — | Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |